UNM

Unum

$91.69

-1.64%
Sep 1, 2026
Bobby Quantitative Model
Unum Group is a leading provider of group and individual income protection insurance, primarily disability insurance, operating in the United States, the United Kingdom, and Poland. As the largest domestic disability insurer, it generates the majority of its premiums from employer-sponsored plans, complemented by life, long-term care, and other group benefits. The current investor narrative centers on the company's robust premium growth, improving margins, and disciplined capital return program, with recent analyst actions and a strong stock rally reflecting optimism about its execution and financial strength.

People also watch

MetLife

MetLife

MET

Analysis
Aflac

Aflac

AFL

Analysis
Prudential Financial

Prudential Financial

PRU

Analysis
Globe Life

Globe Life

GL

Analysis
Voya Financial

Voya Financial

VOYA

Analysis

BobbyInvestment Opinion: Should I buy UNM Today?

Based on the analysis, UNM is rated a Buy. The company's strong revenue growth, improving margins, and attractive forward valuation provide a solid foundation for upside. The analyst consensus of Buy with an average target of $101.85 supports this view, implying a potential return of ~9.5%.

Sign up to view all

UNM 12-Month Price Forecast

The AI assessment is bullish on UNM, driven by its strong revenue growth, attractive valuation, and positive analyst sentiment. The low forward PE suggests the market is pricing in significant earnings growth, which the company appears capable of delivering given its recent performance. However, the medium confidence reflects the risks of earnings volatility and macro uncertainties. If the company continues to execute and growth remains robust, the stock could re-rate higher. Conversely, any signs of deceleration or margin pressure would warrant a downgrade to neutral.

Historical Price
Current Price $91.69
Average Target $100.00
High Target $122.00
Low Target $75.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Unum's 12-month outlook, with a consensus price target around $101.85 and implied upside of +11.1% versus the current price.

Average Target

$101.85

0 analysts

Implied Upside

+11.1%

vs. current price

Analyst Count

covering this stock

Price Range

$88 - $122

Analyst target range

The target price range spans from $88.00 (low) to $122.00 (high), indicating a wide spread of $34.00, which suggests moderate uncertainty. The high target of $122 implies a potential upside of 31.1%, likely assuming continued premium growth, margin expansion, and successful capital deployment. The low target of $88 suggests a downside of 5.4%, possibly pricing in competitive pressures or a cyclical downturn. Recent institutional actions have been predominantly positive, with firms like Evercore ISI, Jefferies, and Wells Fargo reiterating or maintaining Buy/Overweight ratings, reinforcing the bullish sentiment.

Drowning in data?

Find the real signal!

Bulls vs Bears: UNM Investment Factors

Unum presents a compelling bull case with strong revenue growth, improving margins, and a low forward valuation, supported by positive analyst sentiment and robust relative strength. However, the stock's proximity to its 52-week high and earnings volatility introduce risks that could temper upside. The most critical tension is whether the market's expectation of significant earnings growth (implied by the low forward PE) will be realized; if it does, the stock has room to run, but any shortfall could lead to multiple compression and a sharp pullback. Currently, the bull case appears stronger given the fundamental momentum and analyst backing, but investors should monitor execution closely.

Bullish

  • Strong Revenue Growth: Q1 2026 revenue of $3,355.2M grew 9.02% YoY, accelerating from prior quarters. This growth is driven by premium expansion in Unum US and Colonial Life, indicating robust demand for disability and supplemental benefits.
  • Attractive Forward Valuation: Forward PE of 9.84x is significantly below the trailing PE of 18.11x, implying the market expects substantial earnings growth. This low multiple offers a margin of safety and upside potential if growth materializes.
  • Positive Analyst Sentiment: Analyst consensus is Buy with an average target of $101.85, implying ~9.5% upside from the current price of $93.05. Recent actions from Evercore ISI, Jefferies, and Wells Fargo have reiterated Buy/Overweight ratings, reinforcing bullish sentiment.
  • Solid Profitability Metrics: Q1 2026 net income of $232M yielded a net margin of 6.9%, up from 6.1% in Q1 2025. Operating margin improved to 9.0% from 7.9%, indicating effective cost management and operational leverage.

Bearish

  • High Valuation After Rally: The stock trades near its 52-week high of $94.55, with a 1-year gain of 34.23%. This leaves limited room for error, and any disappointment could trigger a sharp correction given the extended valuation.
  • Earnings Volatility: EPS has been volatile, ranging from $0.23 in Q3 2025 to $1.93 in Q2 2025. This inconsistency, partly due to investment gains/losses, makes future earnings less predictable and could lead to negative surprises.
  • Low Analyst Low Target: The analyst low target of $88.00 is only 5.4% below the current price, indicating that even the most bearish analysts see limited downside. However, this also suggests that the stock may be fully valued at current levels.
  • Dependence on Economic Cycle: As a disability and life insurer, UNM's business is sensitive to employment levels and wage growth. An economic downturn could reduce premium growth and increase claims, pressuring margins and earnings.

UNM Technical Analysis

Unum's stock is in a sustained uptrend, with a 1-year price change of +34.23% and a 6-month change of +29.72%. The current price of $93.05 sits near the top of its 52-week range, at approximately 98.4% of the high of $94.55, indicating strong momentum and bullish sentiment. This positioning near highs suggests the market is rewarding the company's performance, though it also raises the risk of short-term overextension.

Beta

0.26

0.26x market volatility

Max Drawdown

-15.3%

Largest decline past year

52-Week Range

$69-$95

Price range past year

Annual Return

+31.2%

Cumulative gain past year

PeriodUNM ReturnS&P 500
1m+6.5%+2.0%
3m+9.8%+1.0%
6m+23.4%+11.8%
1y+31.2%+18.1%
ytd+18.7%+11.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

UNM Fundamental Analysis

Unum's revenue trajectory is solidly growing, with Q1 2026 revenue of $3,355.2 million, up 9.02% year-over-year from $3,077.5 million in Q1 2025. This growth is driven by strong premium expansion across segments, particularly Unum US ($2,065.6 million) and Colonial Life ($520.2 million), which together account for the majority of revenue. The multi-quarter trend shows consistent growth, with revenue rising from $3,202.5 million in Q4 2024 to $3,355.2 million in Q1 2026, indicating a stable and accelerating trajectory.

Quarterly Revenue

$3.4B

2026-03

Revenue YoY Growth

+9.0%

YoY Comparison

Gross Margin

40.3%

Latest Quarter

Free Cash Flow

$538800000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Closed Block
Colonial Life
Unum International
Unum US

Open an Account, get $2 TSLA now!

Valuation Analysis: Is UNM Overvalued?

Given Unum's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 18.11x, while the forward PE is 9.84x, implying the market expects significant earnings growth, likely due to improving margins and continued premium growth. The gap between trailing and forward PE suggests a forward earnings yield of over 10%, which is attractive for a financial services company.

PE

18.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 4x~13x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

13.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks include a moderate debt-to-equity ratio of 0.35, which is manageable but could become a concern if interest rates rise or earnings decline. The company's net margin of 5.7% is relatively thin, leaving little room for cost overruns or claims spikes. Free cash flow of $538.8M TTM provides a cushion, but the payout ratio of 41.5% indicates a significant portion is returned to shareholders, limiting reinvestment capacity. Earnings volatility, as seen in the wide EPS range over recent quarters, adds uncertainty to valuation and dividend sustainability.

FAQ

The key risks include: 1) Earnings volatility, as seen in the wide EPS range from $0.23 to $1.93 over recent quarters, which could lead to negative surprises. 2) Economic sensitivity, as a downturn could reduce premium growth and increase claims, pressuring margins. 3) Regulatory changes, which could impact the disability insurance industry. 4) Competitive pressures from larger insurers. The most severe risk is a recession, which could cause the stock to fall to its 52-week low of $68.70, a 26% downside. Investors should monitor these factors closely.

The 12-month forecast for UNM is moderately bullish. In the base case (50% probability), the stock is expected to trade in the $95-$105 range, reflecting continued growth. In the bull case (30% probability), it could reach $105-$122, driven by strong execution and favorable conditions. In the bear case (20% probability), it could fall to $75-$88 due to economic or company-specific issues. The most likely scenario is the base case, assuming revenue growth remains in the high single digits and margins stabilize. Investors should watch for earnings reports and macro indicators to gauge which scenario is unfolding.

UNM is currently undervalued relative to its growth prospects. The forward PE of 9.84x is below the industry average of around 12x, and the PEG ratio is negative due to expected earnings growth, indicating the market is not fully pricing in future growth. The trailing PE of 18.11x is higher, but this reflects past earnings that were depressed by investment losses. Compared to its own history, the forward PE is at the lower end of its range, suggesting the stock is trading at a discount. The market appears to be pricing in conservative growth expectations, which could lead to upside if the company delivers.

UNM is a good buy for investors seeking a value-oriented insurance stock with growth potential. The stock trades at a forward PE of 9.84x, which is attractive relative to its growth rate, and analysts have an average target of $101.85, implying ~9.5% upside. However, the stock is near its 52-week high, so there is limited margin of safety. The biggest downside risk is a potential economic downturn that could impact premium growth and claims. For long-term investors with a horizon of 3-5 years, UNM offers a favorable risk/reward, but short-term traders may find better entry points on pullbacks.

UNM is more suitable for long-term investment due to its low beta of 0.256, which indicates lower volatility compared to the market, and its stable dividend yield of 2.29%. The company's growth trajectory and attractive valuation provide a solid foundation for long-term capital appreciation. However, short-term traders may also find opportunities given the stock's momentum, but they should be aware of the potential for pullbacks after such a strong rally. A minimum holding period of 3-5 years is recommended to fully realize the benefits of earnings growth and dividend compounding.